all report title image

DIGITAL GENOME MARKET ANALYSIS

Digital Genome Market, By Product (Sequencing and Analyzer Instruments, DNA/RNA Analysis Kits, Sequencing Chips, Sequencing and Analysis Software, and Sample Preparation Instruments), By Application (Clinical, Forensics, Drug Discovery and Development, and Others), By End User (Hospitals, Diagnostic Centers and Forensic Labs, Research Institutes, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

  • Published In : Aug 2024
  • Code : CMI136
  • Pages :161
  • Formats :
      Excel and PDF
  • Industry : Biotechnology

Market Concentration and Competitive Landscape

Digital Genome Market Concentration By Players

Close-monitor your Competitor's Move, Request sample copy

Increasing applications of digital genome in precision medicine

The emergence and increasing applications of digital genome in precision medicine is fueling the growth of the global digital genome market. Precision medicine is an innovative medical model that proposes customization of healthcare, with medical decisions, treatments being tailored to individual genetics, lifestyle, and environmental factors. With digital genome analysis techniques, precision medicine allows the identification of specific biological markers to predict disease risk, identify most effective treatment, and determine optimal treatment regimen for each individual. This is positively impacting the digital genome market as digital genome data is essential for precision medicine applications. Various organizations and healthcare providers are increasingly focusing on incorporating digital genome into their research and practices. For example, the National Human Genome Research Institute, part of National Institutes of Health, launched several large-scale precision medicine initiatives such as 'All of Us Research Program' involving over one million Americans to leverage genomic and other data to accelerate health research. Another example is the UK Biobank project involving half a million U.K. participants which is exploring the role of genetic, lifestyle, and health information to support research into the prevention, treatment, and cures of various illness. The future trends also indicate strong growth prospects for the digital genome market. Advancing genome analysis technologies are making digital genome more efficient, affordable, and accessible. Also, digital genome is finding new applications beyond healthcare such as drug discovery, food safety testing, agriculture, and biotechnology which is expanding the scope of the digital genome market. Additionally, the COVID-19 pandemic has further accelerated focus on precision medicine and genome-based testing worldwide, driving more funding and investments in this field.

Key Players Insights
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche Ltd
  • Illumina, Inc.
  • QIAGEN
  • GenomeMe Inc.
  • NanoString Technologies, Inc.
  • Agilent Technologies
  • Becton Dickinson (BD)
  • bioMérieux SA
  • Pacific Biosciences
  • PerkinElmer Inc.
  • GE Healthcare
  • Invitae Corporation
  • GenMark Diagnostics, Inc.
  • Inscripta, Inc.
  • 10x Genomics
  • Oxford Nanopore Technologies
  • Myriad Genetics

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.